Sign In
Buy NMRD
$0.0002
+0 (+0%)
At Close: Jun 03, 2026
Guarda flagra festa com cerca de 50 pessoas em Rio Preto
05:43pm, Sunday, 28'th Jun 2020
Proprietário do imóvel foi levado à delegacia e autuado por desrespeitar decreto e oferecer bebidas alcoólicas para menores de idade.
Nemaura Medical Interview to Air on Bloomberg International on the RedChip Money Report
11:04am, Friday, 26'th Jun 2020
Nemaura Medical, Inc. (NASDAQ: NMRD) ("Nemaura" or the "Company"), a medical technology company focused on developing micro-systems-based wearable diagnostic devices and currently commercializing suga
Slow Growth Anticipated In The Diabetes Care Devices Market Due To COVID-19
09:25am, Friday, 26'th Jun 2020
The Business Research Company’s Diabetes Care Devices Global Market Report 2020-30: Covid-19 Impact On Diabetes Care Devices Market
Zacks: Analysts Expect DexCom, Inc. (NASDAQ:DXCM) Will Post Earnings of $0.28 Per Share
01:20am, Friday, 26'th Jun 2020
Wall Street brokerages expect that DexCom, Inc. (NASDAQ:DXCM) will post earnings of $0.28 per share for the current fiscal quarter, Zacks Investment Research reports. Ten analysts have provided estima
Nemaura Medical Interview to Air on Bloomberg International on the RedChip Money Report
12:00am, Friday, 26'th Jun 2020
Nemaura Medical, Inc. (NASDAQ: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing micro-systems-based wearable dia
Nemaura Medical (OTCMKTS:NMRD) Trading Up 3%
05:38am, Wednesday, 24'th Jun 2020
Nemaura Medical Inc (OTCMKTS:NMRD)’s stock price rose 3% during trading on Monday . The company traded as high as $16.50 and last traded at $15.27, approximately 43,565 shares changed hands during m
DexCom (NASDAQ:DXCM) Stock Rating Lowered by Zacks Investment Research
01:54am, Wednesday, 24'th Jun 2020
DexCom (NASDAQ:DXCM) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a research report issued on Monday, Zacks.com reports. They currently have a $430.00
Nemaura Medical CEO to Participate in Investor Webinar and Q&A Session on July 7, 2020
12:20pm, Tuesday, 23'rd Jun 2020
Nemaura Medical, Inc. (NASDAQ: NMRD) ("Nemaura" or the "Company"), a medical technology company focused on developing micro-systems-based wearable diagnostic devices and currently commercializing suga
Nemaura Medical CEO to Participate in Investor Webinar and Q&A Session on July 7, 2020
12:00am, Tuesday, 23'rd Jun 2020
Nemaura Medical, Inc. (NASDAQ: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing micro-systems-based wearable dia
The 3 Best Coronavirus Stocks to Buy for Long-Term Investors | The Motley Fool
11:02am, Saturday, 20'th Jun 2020
Strong COVID-19 programs, great growth prospects, attractive dividends. These stocks check off all the boxes.
Better Buy: DexCom vs. Tandem Diabetes Care | The Motley Fool
10:32am, Saturday, 20'th Jun 2020
Which of these two diabetes partners is more likely to be the bigger winner over the long run?
DexCom, Inc. (NASDAQ:DXCM) Director Sells $687,468.75 in Stock
05:52am, Saturday, 20'th Jun 2020
DexCom, Inc. (NASDAQ:DXCM) Director Nicholas Augustinos sold 1,875 shares of the company’s stock in a transaction dated Monday, June 15th. The shares were sold at an average price of $366.65, for a
3 Diabetes Monitoring Companies That Are Recession-Proof | The Motley Fool
03:25pm, Friday, 19'th Jun 2020
As the prevalence of diabetes has grown, these companies are looking for solutions.
